Skip to main content
Year archive

SCANCELL HOLDINGS PLC — 2024 filings

All 43 regulatory filings released by SCANCELL HOLDINGS PLC (SCLP) in 2024, sourced directly from the official regulator.

43 Filings
2024 Period
2024 filings (43)
Filing Released Lang
Result of Retail Offer and Total Voting Rights
Regulatory Filings
2024-12-09 English
Result of Placing and Subscription
Capital/Financing Update
2024-12-05 English
Retail Offer for up to £1 million
Capital/Financing Update
2024-12-04 English
Proposed fundraise in excess of £8.5 million
Capital/Financing Update
2024-12-04 English
Second Commercial License Agreement with Genmab
Regulatory Filings
2024-12-04 English
Positive data from Phase 2 SCOPE trial with SCIB1
Regulatory Filings
2024-11-18 English
Group of companies' accounts made up to 2024-04-30
Regulatory Filings
2024-10-31 English
Result of Annual General Meeting
AGM Information
2024-10-25 English
Holding(s) in Company
Major Shareholding Notification
2024-10-24 English
Scancell Appoints Dr Phil L’Huillier as CEO
Board/Management Information
2024-10-22 English
Notice of AGM
AGM Information
2024-10-01 English
Results Year Ended 30 April 2024
Earnings Release FY 2024
2024-09-24 English
Notice of Final Results
Report Publication Announcement
2024-09-18 English
Strategic Partnership with PharmaJet
Regulatory Filings
2024-09-17 English
Scancell to attend upcoming conferences
Regulatory Filings
2024-09-02 English
Scancell Appoints Dr Nermeen Varawalla as CMO
Board/Management Information
2024-07-30 English
Scancell Appoints Dr Nermeen Varawalla as CMO
Regulatory Filings
2024-07-30 English
Update from iSCIB1+ Clinical Advisory Meeting
Regulatory Filings
2024-07-24 English
Appointment of Dr Florian Reinaud to the Board
Board/Management Information
2024-07-10 English
Extension of Convertible Loan Notes
Capital/Financing Update
2024-07-02 English
Block Listing Return and Total Voting Rights
Share Issue/Capital Change
2024-07-01 English
Change of Nominated Advisor
Board/Management Information
2024-06-21 English
Agreement with major biotech
M&A Activity
2024-06-12 English
Scancell to attend upcoming conferences
Regulatory Filings
2024-05-31 English
Update on ModiFY trial
Regulatory Filings
2024-05-30 English
Scancell to present at ASCO Annual Meeting
Regulatory Filings
2024-05-24 English
Issue of share options
Remuneration Information
2024-05-21 English
Presenting at the Sachs 10th Annual Oncology Forum
Regulatory Filings
2024-05-16 English
Scancell presenting at 21st CIMT Annual Meeting
Regulatory Filings
2024-05-09 English
Presenting at the Annual Immuno-Oncology Summit
Regulatory Filings
2024-04-17 English
Block Listing Six Monthly Return
Share Issue/Capital Change
2024-04-16 English
Employee exercise of share options
Director's Dealing
2024-04-03 English
Scancell to Present at 2024 AACR Annual Meeting
Report Publication Announcement
2024-04-02 English
Scancell Appoints WG as Joint Broker
Board/Management Information
2024-03-28 English
First iSCIB1+ patient dosed
Legal Proceedings Report
2024-03-26 English
Appointment of Sath Nirmalananthan to the Board
Board/Management Information
2024-03-14 English
Scancell Attendance at Upcoming Conferences
Regulatory Filings
2024-03-12 English
Presenting at Next-Gen Immuno-Oncology Conference
Regulatory Filings
2024-03-04 English
Change of Auditor
Regulatory Filings
2024-02-20 English
Directorate Change
Board/Management Information
2024-02-05 English
Interim Results
Interim / Quarterly Report H1 2023
2024-01-30 English
Notice of Interim Results and Presentation
Report Publication Announcement
2024-01-26 English
Update on SCOPE trial
Regulatory Filings
2024-01-17 English